KOSDAQ · Healthcare · ₩59B
₩7,480+7.47%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.0% · as of 26.10.27
Among 34 바이오 peers
Quarterly Revenue Growth
“매출은 회복됐지만 이익 전환은 더 기다려야 해요.”
In the company's words · 2026 2분기 filing